Literature DB >> 23288240

PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites.

Hui-Ju Tsai, Sheng-Chang Wang, Jia-Ni Tian, Tsung-Kai Chang, Ing-Kang Ho, Chin-Fu Hsiao, Chia-Hui Chen, Happy Kuy-Lok Tan, Linen Lin, Chi-Shin Wu, Lien-Wen Su, Chieh-Liang Huang, Yi-Hong Yang, Ming-Lun Liu, Keh-Ming Lin, Yu-Li Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23288240     DOI： 10.1097/01.jcp.0000426186.34421.de

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

1.  Genetics and pharmacogenetics of substance use disorders.

Authors:  Pao-Luh Tao; Li-Shiun Chen; Chih-Ken Chen; Yu-Li Liu
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

Review 2.  Pharmacogenetics of Methadone Response.

Authors:  Francina Fonseca; Marta Torrens
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

3.  Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.

Authors:  Hsin-Chou Yang; Shih-Kai Chu; Chieh-Liang Huang; Hsiang-Wei Kuo; Sheng-Chang Wang; Sheng-Wen Liu; Ing-Kang Ho; Yu-Li Liu
Journal:  PLoS Genet       Date:  2016-03-24       Impact factor: 5.917
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.